Ozer H - Search Results

1

Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.

Cherry M, Khawandanah M, Zhao ZJ, Srour S, Ozer H, Selby G, Ghabache B, Al-Kali A. Cherry M, et al. Among authors: ozer h. Ann Hematol. 2015 Apr;94(4):717-9. doi: 10.1007/s00277-014-2247-1. Epub 2014 Nov 9. Ann Hematol. 2015. PMID: 25380996 Clinical Trial. No abstract available.

2

First-Cycle CSF use in breast cancer and NHL: guidelines and recommendations.

Al-Kali A, Ozer H. Al-Kali A, et al. Among authors: ozer h. Oncology (Williston Park). 2006 Dec;20(14 Suppl 9):7-12. Oncology (Williston Park). 2006. PMID: 17370923 Free article. Review.

3

Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.

Kamble R, Pant S, Selby GB, Kharfan-Dabaja MA, Sethi S, Kratochvil K, Kohrt N, Ozer H. Kamble R, et al. Among authors: ozer h. Transfusion. 2005 Jun;45(6):874-8. doi: 10.1111/j.1537-2995.2005.04178.x. Transfusion. 2005. PMID: 15934984

4

Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN. Kamble RT, et al. Among authors: ozer h. Biol Blood Marrow Transplant. 2006 May;12(5):506-10. doi: 10.1016/j.bbmt.2006.01.004. Biol Blood Marrow Transplant. 2006. PMID: 16635785 Free article.

5

Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining.

Kharfan-Dabaja MA, Patel SA, Osunkoya AO, Kojouri K, Kamble R, Yang J, Hashmi M, Ozer H, Selby GB. Kharfan-Dabaja MA, et al. Among authors: ozer h. Clin Lab Haematol. 2006 Aug;28(4):254-8. doi: 10.1111/j.1365-2257.2006.00802.x. Clin Lab Haematol. 2006. PMID: 16898965

6

A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

Al-Kali A, Cherry M, Kimmell K, Holter J, Kern W, Gehrs B, Ozer H, Selby G. Al-Kali A, et al. Among authors: ozer h. Cancer Genet Cytogenet. 2010 Dec;203(2):348-51. doi: 10.1016/j.cancergencyto.2010.09.004. Cancer Genet Cytogenet. 2010. PMID: 21156258 No abstract available.

7

Protein kinase C blockade inhibits differentiation of myeloid blasts into dendritic cells by calcium ionophore A23187.

Li Q, Ozer H, Lindner I, Lee KP, Kharfan-Dabaja MA. Li Q, et al. Among authors: ozer h. Int J Hematol. 2005 Feb;81(2):131-7. doi: 10.1532/ijh97.na0405. Int J Hematol. 2005. PMID: 15765781

8

The timing of chemotherapy-induced neutropenia and its clinical and economic impact.

Ozer H. Ozer H. Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):11-5. Oncology (Williston Park). 2006. PMID: 16736983 Free article. Review.

9

Neratinib: an oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer.

Bose P, Ozer H. Bose P, et al. Among authors: ozer h. Expert Opin Investig Drugs. 2009 Nov;18(11):1735-51. doi: 10.1517/13543780903305428. Expert Opin Investig Drugs. 2009. PMID: 19780706 Review.

10

Activity of combination chemotherapy, docetaxel and epirubicin as neoadjuvant therapy for women with breast cancer.

Tfayli A, Holter J, Bova A, Venkatappa S, Bullock S, Dooley W, Ozer H. Tfayli A, et al. Among authors: ozer h. Anticancer Res. 2006 Nov-Dec;26(6C):4911-6. Anticancer Res. 2006. PMID: 17214361 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

611 results

Search Page

Filters